Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
Clinical trial NCT01951326 · COMPLETED
Trial details
- NCT number
- NCT01951326
- Sponsor
- RedHill Biopharma Limited
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-01
- Primary completion
- 2018-05-01
- Enrollment
- 331
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.